INSIGHTS ON CLINICAL TRIAL DESIGN
-
Why Do Clinical Trials Cost So Much? Looking Beyond The Obvious
The true cost of research goes beyond budgets to design, data, and execution inefficiencies. Streamlining processes and early decisions reduces delays, controls costs, and improves study quality.
-
Improving The eCOA Experience
Discover how template-driven builds and reuse can slash eCOA timelines by 50% while solving the licensing and translation hurdles that delay First Patient In.
-
Investigator SmartSelect
This advanced recommendation engine identifies protocol-specific investigators in just minutes, dramatically shortening a process that typically takes four to six weeks.
-
Beyond The Database: Reaching Real Patients In Real Communities
There’s fatigue around “database-only” recruitment tactics. This presentation spotlights how patient-centric, local engagement are outperforming traditional pipelines.
-
Key Risk Areas that Can Derail Clinical Trials with Ocular Endpoints1/15/2025
By embracing point-of-need models and strategic collaborations, sponsors and CROs can streamline ophthalmic trials and maximize ROI while advancing sight-saving therapies.
-
How Digitized Protocols Are Accelerating Clinical Research4/15/2025
Digitized protocols, enhanced by artificial intelligence (AI), are transforming clinical trial operations by accelerating document generation, system integration, and trial optimization.
-
Best Practices For Operationalizing Global, Early-Phase Oncology Trials9/10/2025
In this presentation, industry experts will share real-world lessons learned from managing global early-phase oncology trials.
-
GA Screening: Early Detection For Future Trial Recruitment4/9/2026
Community-based screenings identify undiagnosed eye disease at high rates, creating a scalable, high-trust pathway for early intervention and improved clinical research recruitment.
-
Human Abuse Potential: Participant Recruitment5/1/2026
Take a look at the strategies behind successful human abuse potential studies, from volunteer recruitment models to retention challenges, and how participant experience directly impacts data quality.
CLINICAL TRIAL DESIGN SOLUTIONS
-
Altasciences has over 25 years of experience in metabolic diseases and supports every stage of the development process, from discovery to clinical trials — and beyond.
-
When risk-based oversight is reduced to a compliance checkbox, critical signals can be missed and escalate into systemic issues.
-
Precision starts at collection. The integrity of trial data depends on accurate, compliant, and traceable sample handling, but standard kitting isn’t built for the demands of biomarker-driven research.
-
Validate endpoint performance and security before deployment with structured UAT that reduces risk, ensures compliance, and enhances user experience through real-world testing.
-
The Australian Advantage is about saving time and minimizing costs while generating internationally accepted data in preparation for the next Phase.